These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34003560)

  • 1. Outcomes of allogeneic transplantation for hemoglobin Bart's hydrops fetalis syndrome in Hong Kong.
    Chan WYK; Lee PPW; Lee V; Chan GCF; Leung W; Ha SY; Cheuk DKL
    Pediatr Transplant; 2021 Sep; 25(6):e14037. PubMed ID: 34003560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and morbidities of patients who survive haemoglobin Bart's hydrops fetalis syndrome: 20-year retrospective review.
    Chan WY; Leung AW; Luk CW; Li RC; Ling AS; Ha SY
    Hong Kong Med J; 2018 Apr; 24(2):107-118. PubMed ID: 29632273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
    Songdej D; Babbs C; Higgs DR;
    Blood; 2017 Mar; 129(10):1251-1259. PubMed ID: 28057638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic stem cell transplantation in Hong Kong.
    Lie AK; Au WY; Liang R
    Hong Kong Med J; 2009 Jun; 15(3 Suppl 3):17-21. PubMed ID: 19494391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-emergence of late presentations of fetal haemoglobin Bart's disease in Hong Kong.
    Kwan WY; So CH; Chan WP; Leung WC; Chow KM
    Hong Kong Med J; 2011 Dec; 17(6):434-40. PubMed ID: 22147311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental transcriptome sequencing combined with bioinformatics predicts potential genes and circular RNAs associated with hemoglobin Bart's hydrops fetalis syndrome.
    Deng L; Lu Y; Yang D; Yang F; Ruan H; Wei C; Lai K; Pang L
    J Obstet Gynaecol Res; 2022 Feb; 48(2):313-327. PubMed ID: 34935248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified PGD of common determinants of haemoglobin Bart's hydrops fetalis syndrome using multiplex-microsatellite PCR.
    Wang W; Yap CH; Loh SF; Tan AS; Lim MN; Prasath EB; Chan ML; Tan WC; Jiang B; Yeo GH; Mathew J; Ho A; Ho SS; Wong PC; Choolani MA; Chong SS
    Reprod Biomed Online; 2010 Nov; 21(5):642-8. PubMed ID: 20864413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal eradication of Hb Bart's hydrops fetalis.
    Tongsong T; Wanapirak C; Sirivatanapa P; Sa-nguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P; Steger HF; Sekararithi R; Tuggapichitti A
    J Reprod Med; 2001 Jan; 46(1):18-22. PubMed ID: 11209626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Hb Bart's Hydrops Fetalis Caused by - -
    He S; Li J; Huang P; Zhang S; Lin L; Zuo Y; Tian X; Zheng C; Qiu X; Chen B
    Hemoglobin; 2018 Jan; 42(1):61-64. PubMed ID: 29493331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia.
    King AJ; Higgs DR
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):353-360. PubMed ID: 30504332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20 years review of antenatal diagnosis of haemoglobin Bart's disease and treatment with intrauterine transfusion.
    Hui PW; Pang P; Tang MHY
    Prenat Diagn; 2022 Aug; 42(9):1155-1161. PubMed ID: 35226373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive prenatal diagnosis of α-thalassemia to control Hb Bart's hydrops fetalis syndrome: 15 years of experience.
    Lai K; Li S; Lin W; Yang D; Chen W; Li M; Pang L; Chen P
    Arch Gynecol Obstet; 2018 Aug; 298(2):307-311. PubMed ID: 29948167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
    Amid A; Chen S; Athale U; Charpentier K; Merelles-Pulcini M; Odame I; Kirby-Allen M
    Haematologica; 2018 May; 103(5):e184-e187. PubMed ID: 29371322
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful mismatched sibling cord blood transplant in Hb Bart's disease.
    Zhou X; Ha SY; Chan GC; Luk CW; Chan V; Hawkins B; Lam YH; Liang RH; Lau YL
    Bone Marrow Transplant; 2001 Jul; 28(1):105-7. PubMed ID: 11498754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant.
    Chan WYK; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
    Pediatr Transplant; 2021 Aug; 25(5):e13945. PubMed ID: 33314508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal control of Hb Bart's hydrops fetalis: a two-year experience at a mainland Chinese hospital.
    Liao C; Pan M; Han J; Yang X; Zhen L; Li J; Li R; Li DZ
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):413-5. PubMed ID: 24766075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.